Morland Thomas B, Synnestvedt Marie, Honeywell Steven, Yang Feifei, Armstrong Katrina, Guerra Carmen
1 Geisinger Health System, Danville, PA.
2 University of Pennsylvania Health System, Philadelphia, PA.
Am J Med Qual. 2017 May/Jun;32(3):292-298. doi: 10.1177/1062860616646848. Epub 2016 May 5.
Performance incentives for preventive care may encourage inappropriate testing, such as cancer screening for patients with short life expectancies. Defining screening colonoscopies for patients with a >50% 4-year mortality risk as inappropriate, the authors performed a pre-post analysis assessing the effect of introducing a cancer screening incentive on the proportion of screening colonoscopy orders that were inappropriate. Among 2078 orders placed by 23 attending physicians in 4 academic general internal medicine practices, only 0.6% (n = 6/1057) of screening colonoscopy orders in the preintervention period and 0.6% (n = 6/1021) of screening colonoscopy orders in the postintervention period were deemed "inappropriate." This study found no evidence that the incentive led to an increase in inappropriate screening colonoscopy orders.
预防性医疗的绩效激励措施可能会鼓励不适当的检查,比如对预期寿命较短的患者进行癌症筛查。作者将4年死亡风险超过50%的患者的结肠镜筛查定义为不适当,并进行了一项前后分析,评估引入癌症筛查激励措施对不适当的结肠镜筛查医嘱比例的影响。在4个学术性普通内科诊所的23位主治医师开出的2078份医嘱中,干预前期结肠镜筛查医嘱中只有0.6%(n = 6/1057)被视为“不适当”,干预后期这一比例为0.6%(n = 6/1021)。该研究没有发现证据表明这种激励措施会导致不适当的结肠镜筛查医嘱增加。